These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 3718591)

  • 1. Metabolic fate of the new cardiotonic denopamine in animals. 4th communication: effects of coadministered drugs on the plasma concentration and metabolism of denopamine in dogs.
    Furuuchi S; Naito K; Yamada Y; Otsuka M; Harigaya S
    Arzneimittelforschung; 1986 Apr; 36(4):665-7. PubMed ID: 3718591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic fate of the new cardiotonic denopamine in animals. 1st communication: absorption, distribution and excretion in the rat, rabbit and dog.
    Naito K; Furuuchi S; Yamada Y; Otsuka M; Harigaya S
    Arzneimittelforschung; 1986 Apr; 36(4):643-51. PubMed ID: 3718588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic fate of the new cardiotonic denopamine in animals. 2nd communication: tissue accumulation in the rat after consecutive oral administration of 14C-denopamine.
    Naito K; Furuuchi S; Usuki S; Otsuka M; Harigaya S
    Arzneimittelforschung; 1986 Apr; 36(4):652-5. PubMed ID: 3718589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between positive inotropic action and blood levels of denopamine in cats.
    Naito K; Otsuka M; Harigaya S; Nagao T; Narita H
    Arzneimittelforschung; 1985; 35(5):833-5. PubMed ID: 4026907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolism of denopamine, a new cardiotonic agent, in the rat and dog.
    Furuuchi S; Naito K; Otsuka M; Harigaya S
    Drug Metab Dispos; 1985; 13(5):620-6. PubMed ID: 2865114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic fate of the new cardiotonic denopamine in animals. 3rd communication: placental transfer and excretion into milk in the rat.
    Naito K; Furuuchi S; Otsuka M; Harigaya S
    Arzneimittelforschung; 1986 Apr; 36(4):656-65. PubMed ID: 3718590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro metabolism of the new cardiotonic agent denopamine (TA-064) by rat and rabbit liver preparations. Oxidation, methylation, and glucuronidation.
    Suzuki T; Hashimura Y; Takeyama S
    Drug Metab Dispos; 1985; 13(2):246-54. PubMed ID: 2859176
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiovascular effects of the new positive inotropic agent denopamine with special reference to species difference and the effect on failing heart.
    Ikeo T; Nagao T; Murata S; Yabana H; Sato M; Nakajima H
    Arzneimittelforschung; 1986 Jul; 36(7):1063-8. PubMed ID: 3768073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Absorption, distribution and excretion of [carbonyl-14C]mosapride citrate after a single oral administration in rats, dogs and monkeys.
    Matsumoto S; Tagawa M; Amejima H; Nakao M; Kagemoto A; Fujii T; Miyazaki H; Sekine Y
    Arzneimittelforschung; 1993 Oct; 43(10):1084-94. PubMed ID: 8267675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison between the effects of diltiazem and isosorbide dinitrate on digoxin pharmacodynamics and kinetics in the treatment of patients with chronic ischemic heart failure.
    Mahgoub AA; El-Medany AH; Abdulatif AS
    Saudi Med J; 2002 Jun; 23(6):725-31. PubMed ID: 12070557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiovascular effects and plasma levels of denopamine (TA-064), a new positive inotropic agent, in chronically instrumented dogs.
    Ikeo T; Nagao T; Suzuki T; Yabana H; Nakajima H
    Jpn J Pharmacol; 1985 Oct; 39(2):191-9. PubMed ID: 4087566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Details of mode and mechanism of action of denopamine, a new orally active cardiotonic agent with affinity for beta 1-receptors.
    Yokoyama H; Yanagisawa T; Taira N
    J Cardiovasc Pharmacol; 1988 Sep; 12(3):323-31. PubMed ID: 2464105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies on the metabolism and disposition of the new retinoid 4-[(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthyl)carbamoyl] benzoic acid. 4th communication: absorption, metabolism, excretion and plasma protein binding in various animals and man.
    Mizojiri K; Okabe H; Sugeno K; Misaki A; Ito M; Kominami G; Esumi Y; Takaichi M; Harada T; Seki H; Inaba A
    Arzneimittelforschung; 1997 Mar; 47(3):259-69. PubMed ID: 9105544
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies on the affinity and selectivity of denopamine (TA-064), a new cardiotonic agent, for beta-adrenergic receptors.
    Naito K; Nagao T; Otsuka M; Harigaya S; Nakajima H
    Jpn J Pharmacol; 1985 Jul; 38(3):235-41. PubMed ID: 2997524
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of the new thyrotropin releasing hormone analogue montirelin hydrate. 1st communication: plasma concentrations, metabolism and excretion after a single intravenous administration to rats, dogs and monkeys.
    Sugimoto T; Hayashi T; Okita A; Morino A
    Arzneimittelforschung; 1996 Feb; 46(2):106-13. PubMed ID: 8720298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term denopamine therapy for hemodialysis patients with chronic heart failure.
    Takata Y; Tsuchihashi T; Nakamura S; Hirota Y
    Clin Cardiol; 1995 Jul; 18(7):408-11. PubMed ID: 7554546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pharmacokinetics of AR-L 115 BS in rhesus monkeys (author's transl)].
    Mierau J
    Arzneimittelforschung; 1981; 31(1a):221-5. PubMed ID: 7195226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of GTP on the affinity of denopamine, a new cardiotonic agent, for beta-adrenergic receptors of turkey erythrocytes and rat reticulocyte membranes.
    Naito K; Nagao T; Ono Y; Otsuka M; Harigaya S; Nakajima H
    Jpn J Pharmacol; 1985 Dec; 39(4):541-9. PubMed ID: 3005732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Acute and sustained hemodynamic effects of a new inotropic agent TA-064 (Denopamine) in patients with refractory heart failure with special reference to dose-response effects].
    Matsumoto N; Ito N; Kawagoe Y; Matsumura K; Honda T; Horie T; Takahashi S; Kimata S; Hirosawa K
    Kokyu To Junkan; 1986 Oct; 34(10):1113-20. PubMed ID: 3797842
    [No Abstract]   [Full Text] [Related]  

  • 20. The cardioprotector monoHER does not interfere with the pharmacokinetics or the metabolism of the cardiotoxic agent doxorubicin in mice.
    Abou El Hassan MA; Kedde MA; Zwiers UT; Bast A; van der Vijgh WJ
    Cancer Chemother Pharmacol; 2003 Apr; 51(4):306-10. PubMed ID: 12721758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.